| Product dosage: 98mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.45 | $49.06 (0%) | 🛒 Add to cart |
| 30 | $2.34 | $73.58 $70.08 (5%) | 🛒 Add to cart |
| 60 | $2.29 | $147.17 $137.16 (7%) | 🛒 Add to cart |
| 90 | $2.25 | $220.75 $202.23 (8%) | 🛒 Add to cart |
| 120 | $2.12 | $294.34 $254.29 (14%) | 🛒 Add to cart |
| 180 | $2.05 | $441.51 $369.42 (16%) | 🛒 Add to cart |
| 270 | $1.99 | $662.26 $537.62 (19%) | 🛒 Add to cart |
| 360 | $1.79
Best per pill | $883.01 $644.74 (27%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
contrave
Contrave represents one of the more interesting pharmacological approaches to chronic weight management we’ve seen in recent years. It’s not a single molecule but rather a fixed-dose combination product containing naltrexone HCl and bupropion HCl in an extended-release formulation. Many patients come to our obesity medicine clinic after failing multiple dietary approaches, and this medication often becomes part of a comprehensive discussion about pharmacological options. I remember when we first started prescribing it back in 2015—there was considerable skepticism among our endocrinology group about combining two existing drugs rather than developing something entirely novel.
Mysimba: Appetite Regulation and Weight Management - Evidence-Based Review
Mysimba represents one of the more interesting pharmacological approaches to weight management we’ve seen in recent years. Unlike single-agent therapies, it combines two established medications—naltrexone and bupropion—in an extended-release formulation specifically designed to target the hypothalamic melanocortin system and mesolimbic dopamine pathway. What’s fascinating is how these components work synergistically rather than simply additively. 1. Introduction: What is Mysimba? Its Role in Modern Medicine Mysimba (known as Contrave in some markets) is a prescription-only weight management medication containing fixed-dose combination of naltrexone hydrochloride and bupropion hydrochloride in an extended-release formulation.
Xenical: Clinically Proven Weight Management Aid for Obesity - Evidence-Based Review
Orlistat, marketed as Xenical, represents one of the few FDA-approved pharmacological interventions for chronic weight management that operates through a distinctly peripheral mechanism—it works in the gut lumen without systemic absorption. This 120 mg prescription capsule contains the active ingredient orlistat, a potent lipase inhibitor that blocks dietary fat absorption by about 30%. Unlike centrally-acting appetite suppressants that carry risks of cardiovascular or psychiatric side effects, Xenical offers a mechanically straightforward approach: it inactivates gastric and pancreatic lipases in the gastrointestinal tract, preventing the hydrolysis of triglycerides into absorbable free fatty acids and monoglycerides.
a ret gel
Product Description: A Ret Gel represents a significant advancement in topical retinoid therapy, combining stabilized tretinoin with enhanced penetration technology. This medical-grade formulation addresses the fundamental challenge of retinoid instability while maximizing bioavailability. The gel matrix creates a controlled-release environment that maintains tretinoin’s molecular integrity while minimizing the irritation commonly associated with traditional retinoid formulations. What sets this apart isn’t just the active ingredient—it’s the delivery system that makes the difference in clinical outcomes.
abana
Product Description: Abana represents one of those interesting formulations that bridges traditional Ayurvedic wisdom with modern cardiovascular science. I first encountered it during my cardiology fellowship when our department was exploring integrative approaches to lipid management. The formula combines herbs like Terminalia arjuna, Withania somnifera, and Ocimum sanctum with minerals in a specific preparation that’s been used for decades, though Western literature has been slow to catch up. ## 1. Introduction: What is Abana?
abhigra
Product Description Abhigra represents a novel class of phytopharmaceutical-grade dietary supplements derived from a standardized extract of Boswellia serrata, specifically optimized for enhanced bioavailability. Unlike conventional boswellia supplements, Abhigra utilizes a proprietary lipid-based delivery system that significantly increases the absorption of the active boswellic acids, particularly AKBA (3-O-acetyl-11-keto-β-boswellic acid). The formulation was developed through a collaboration between rheumatologists and pharmacognosy experts who recognized the limitations of existing anti-inflammatory supplements. We kept hitting the same wall with patients - they’d take standard boswellia products but achieve negligible serum levels.
abilify
Aripiprazole, marketed under the brand name Abilify, represents a significant advancement in the atypical antipsychotic class with its unique pharmacodynamic profile. This second-generation antipsychotic functions as a partial dopamine D2 and serotonin 5-HT1A receptor agonist while simultaneously acting as a 5-HT2A receptor antagonist. The clinical implications of this mechanism are profound, offering stabilization of dopamine neurotransmission rather than complete blockade, which translates to improved tolerability regarding extrapyramidal symptoms and prolactin elevation compared to conventional antipsychotics.
Acamprol: Neurotransmitter Modulation for Cognitive and Neurological Support - Evidence-Based Review
Product Description Acamprol is an orally administered dietary supplement specifically formulated to support neurological health and cognitive function. It falls into the category of medical foods or nutraceuticals designed to provide targeted nutritional support for conditions involving neurotransmitter imbalance and neuronal excitability. The product is typically available in delayed-release tablet form, intended to ensure optimal absorption in the gastrointestinal tract. Its development was driven by the growing need for non-pharmaceutical interventions in managing functional neurological symptoms, particularly in cases where conventional medications are contraindicated or poorly tolerated.
Accufine: Continuous Glucose Monitoring Without Calibration - Evidence-Based Review
Product Description Accufine represents a significant advancement in non-invasive blood glucose monitoring technology. This Class II medical device utilizes a proprietary multi-sensor array with advanced photoplethysmography and impedance spectroscopy to provide continuous glucose readings without fingerstick calibration. The system consists of a discreet wearable sensor that transmits data to a dedicated mobile application, allowing patients and clinicians to track glycemic patterns in real-time. What sets Accufine apart isn’t just the technology itself, but how we arrived at this particular configuration - a journey marked by both breakthroughs and considerable setbacks that nearly derailed the project entirely.